This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Compugen Ltd. Corporation. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Dani Eshel: Innovator in MCP-1 Splice Variants
Introduction
Dani Eshel is a prominent inventor based in Karkur, Israel. She has made significant contributions to the field of biotechnology, particularly in the development of novel MCP-1 splice variants. Her work has implications for treating various disorders related to MCP-1.
Latest Patents
Dani Eshel holds a patent for "MCP-1 splice variants and methods of using same." This patent includes novel MCP-1 splice variant polypeptides and polynucleotides encoding these variants. The pharmaceutical compositions derived from her research are designed to treat various MCP-1 related disorders and can also be used for diagnosing and determining predisposition and prognosis of these disorders. She has 1 patent to her name.
Career Highlights
Dani Eshel is currently associated with Compugen Ltd. Corporation, where she continues her innovative work in biotechnology. Her research has positioned her as a key figure in the development of therapeutic solutions for complex medical conditions.
Collaborations
Dani collaborates with talented individuals in her field, including Zurit Levine and Amir Toporik. Their combined expertise enhances the research and development efforts at Compugen.
Conclusion
Dani Eshel's contributions to the field of biotechnology, particularly through her patent on MCP-1 splice variants, highlight her role as an influential inventor. Her work not only advances scientific knowledge but also holds promise for improving patient outcomes in various medical conditions.